trending Market Intelligence /marketintelligence/en/news-insights/trending/l33u1-ockdxsl7cp7od88q2 content esgSubNav
In This List

Ziopharm Oncology nominates board member

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Ziopharm Oncology nominates board member

Ziopharm Oncology Inc. named Scott Braunstein for election to its board at the company's annual meeting of stockholders on Sept. 18.

Braunstein has been a partner at Aisling Capital Management LP since August 2015. He has also served as COO of Pacira Pharmaceuticals Inc.